Actually it is beyond a Phase III asset as it made it all the way to approval (in France).
One thing I think investors should look into in detail is Phase III breast cancer trial paper [1]. I have attached it, because I don’t think a lot of people have had a chance to read it.
1. J. Natl. Cancer Inst. 1991 Cowan.pdf
General Comments / Chat, page-82
-
-
- There are more pages in this discussion • 10,931 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M |
Open | High | Low | Value | Volume |
$1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 8662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.690 |
2 | 6661 | 1.685 |
1 | 727 | 1.680 |
1 | 5970 | 1.675 |
1 | 727 | 1.670 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 8662 | 1 |
1.730 | 943 | 1 |
1.740 | 500 | 1 |
1.745 | 727 | 1 |
1.755 | 727 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |